US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.42

-0.4600-1.13%

Volume:85.59K

Turnover:3.43M

Market Cap:301.13M

PE:- -

High:40.43

Open:40.36

Low:39.72

Close:40.88

52wk High:43.44

52wk Low:23.90

Shares:7.45M

Float Shares:7.45M

Volume Ratio:0.47

T/O Rate:1.15%

Dividend:0.28

Dividend Rate:0.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Twist Bioscience CEO Emily M. Leproust Disposes of USD 910,033 in Common Shares

Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast

Moderna, Merck Climb on Collaboration with Tempus

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT

Novartis announces FDA approval of Rhapsido for symptomatic dermographism

Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)

Twist Bioscience Price Target Raised to $215.00/Share from $112.00 by Barclays

Moderna Price Target Raised to $95.00/Share from $89.00 by Morgan Stanley

AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays

Morgan Stanley Adjusts Price Target on Moderna to $95 From $89

MT Newswires Live

Tempus AI announces multi-year collaboration with Moderna, Merck

Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support

Tempus Announces Multi-Year Collaboration with Moderna and Merck

THOMSON REUTERS

Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare

Barclays Remains a Buy on Twist Bioscience (TWST)

Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketf.com/stock/IDNA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":40.42,"timestamp":1791489600000,"preClose":40.88,"halted":0,"volume":85591,"delay":0,"changeRate":-0.011252446183953053,"floatShares":7450000,"shares":7450000,"eps":0,"marketStatus":"Pre-Mkt","change":-0.46,"latestTime":"10-09 06:57:00 EDT","open":40.36,"high":40.43,"low":39.72,"amount":3429583.43904,"amplitude":0.017368,"askPrice":54.27,"askSize":100,"bidPrice":35.56,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791552600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":40.42,"sharesOutstanding":5100000,"nav":40.752915,"aum":307684508.25,"dividendRate":0.006977,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":40.42,"preClose":40.42,"latestTime":"19:56 EDT","volume":5346,"amount":216103.66,"timestamp":1791503775220,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4660522394556619,"impliedVol":0.1441,"impliedVolPercentile":0.34},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":7450000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4660522394556619,"shares":7450000,"dividePrice":0.282,"high":40.43,"amplitude":0.017368,"preClose":40.88,"low":39.72,"week52Low":23.9,"pbRate":"--","week52High":43.44,"institutionHeld":0,"latestPrice":40.42,"eps":0,"divideRate":0.006977,"volume":85591,"delay":0,"ttmEps":0,"open":40.36,"prevYearClose":26.19,"prevWeekClose":41.65,"prevMonthClose":42.32,"prevQuarterClose":42.32,"fiveDayClose":41.64,"twentyDayClose":37.88,"sixtyDayClose":33.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673483150","title":"Moderna Inc. Stock Rises 4.8%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2673483150","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673483150?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:33","pubTimestamp":1791405180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 4.8% to $196.48 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 27,538.69 and Dow Jones Industrial Average falling 0.7% to 51,179.87.Moderna Inc. closed 7.4% short of its 52-week high of $212.22, which the company achieved on October 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $258.45, Pfizer Inc. rose 1.8% to $28.00, and Gilead Sciences Inc. rose 1.82% to $146.85.Trading volume totaled 14.6 million, compared to the 50-day average of 20.7 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","LU0823416689.USD","SG9999015978.USD","LU0109394709.USD","IE00B7SZLL34.SGD","LU1839511570.USD","BMED","IE00BKVL7J92.USD","IE00B3T34201.USD","BIB","BK4578","IDNA","IE00BZ1G4Q59.USD","MRNX","IE00B19Z3581.USD","MRNA","BK4585","BK4588","LU0861579265.USD","LU1778281490.HKD","IBB","LU2112291526.USD","MRNY","GNOM","LU0289739699.SGD","LU1674673428.USD","LU1061106388.HKD","IE00BSNM7G36.USD","LU0965508806.USD","TMED","BK4534","IE0002270589.USD","BK4566","LU0965509010.AUD","IBBQ","GILD","LU0058720904.USD","BK4550","SG9999015952.SGD","BK4551","BK4583","BK4501","LU2324357040.USD","TBXU","SG9999015986.USD","BK4548","WDNA","LU2089984988.USD","BBH","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673101011","title":"Twist Bioscience CEO Emily M. Leproust Disposes of USD 910,033 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2673101011","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673101011?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:05","pubTimestamp":1791403549,"startTime":"0","endTime":"0","summary":"Twist Bioscience CEO Emily M. Leproust disposes of USD 910,033 in common sharesTwist Bioscience CEO Emily M. Leproust sold 4,548 shares of common stock on Oct. 5, 2026.Sales were disclosed at weighted","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDLthKxF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Twist Bioscience CEO Emily M. Leproust Disposes of USD 910,033 in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","ARKG","BK4139","IDNA","BK4588","BK4585","TWST","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673106080","title":"Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2673106080","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673106080?lang=en_us&edition=fundamental","pubTime":"2026-10-08 04:00","pubTimestamp":1791403217,"startTime":"0","endTime":"0","summary":"Vertex to report Q3 2026 financial results, host conference call and webcastVertex will report third-quarter 2026 financial results on Nov. 2, 2026.Conference call and webcast set for Nov. 2, 2026 at ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL13mQMk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","PBE","LU2462157665.USD","IE0009355771.USD","LU0234570918.USD","BK4532","LU0889565916.HKD","LU2468319806.SGD","IDNA","BK4139","LU0058720904.USD","VRTX","BBH","GNMX","BK4567","LU0079474960.USD","LU1035775433.USD","LU0432979614.USD","LU0256863811.USD","SG9999001176.USD","SGXZ57979304.SGD","LU1093756325.SGD","LU1674673691.USD","LU2324357040.USD","LU2456880835.USD","LU1778281490.HKD","IE00B19Z3581.USD","LU2237438978.USD","TBXU","IE00B894F039.SGD","IE00B19Z9P08.USD","IE0002141913.USD","IE00B19Z3B42.SGD","SG9999013999.USD","IE00B19Z9Z06.USD","LU0823416689.USD","BK4588","IE00BJT1NW94.SGD","LU1430594728.SGD","LU0109394709.USD","BK4585","LU1674673428.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2362541513.USD","LU2089984988.USD","SG9999001176.SGD","BIB","LU0320765992.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011275","title":"Moderna, Merck Climb on Collaboration with Tempus","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011275","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011275?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:33","pubTimestamp":1791390807,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna, Merck climb on collaboration with Tempus** Pharmaceutical companies ModernaMRNA.Oand MerckMRK.Oclimb 3.25% to $193.56 and 1.46% to $144.01, respectively** AI healthcare technology compan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL6N45T116:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FHLC","LU2468319806.SGD","LU1929549753.HKD","BK4559","IXJ","LU1585245621.USD","LU1069347547.HKD","LU0320765646.SGD","LU1057294990.SGD","LU0289961442.SGD","SG9999014542.SGD","SG9999013999.USD","LU1699723380.USD","BK4550","LU0070302665.USD","BK4121","LU2112291526.USD","MRNA","LU0980610538.SGD","LU1037948897.HKD","LU0106261372.USD","LU2125909593.SGD","LU1917777945.USD","LU2106854487.HKD","LU1093756168.USD","LU1934455863.HKD","LU0266013472.USD","LU0058720904.USD","TEM","BMED","IE0009355771.USD","LU1066051498.USD","LU2433249047.HKD","HRTS","LU2125154778.USD","LU1934455277.USD","IE00BBT3K403.USD","LU0098860793.USD","MRNY","IE000M9KFDE8.USD","LU1923622614.USD","LU0289739699.SGD","LU1934455194.USD","SG9999001176.USD","XLV","SG9999001176.SGD","PPH","LU1035773651.USD","LU0289739343.SGD","LU0162691827.USD","IDNA","LU0238689110.USD","LU2125154935.USD","HEAL","GNOM","SG9999002232.USD","LU1201861249.SGD","BK4532","MRK","LU0942090050.USD","LU1116320901.HKD","BK4007","IE00BN8TJ469.HKD","IE00B4R5TH58.HKD","BK4568","IHE","LU0965509101.SGD","LU2023250504.SGD","LU1861558580.USD","SG9999015341.SGD","IE00BJJMRZ35.SGD","LU0648001328.SGD","BK4613","LU0859254822.USD","LU2357627491.SGD","LGHT","RXL","LU0965509010.AUD","LU0069063385.USD","LU1974910355.USD","BK4139","SG9999002224.SGD","LU0057025933.USD","BK4611","BK4533","GDOC","LU1430594728.SGD","TEMT","LU0985320562.USD","IE00BLSP4452.SGD","BK4501","ARKG","IE00BLSP4239.USD","LU0861579265.USD","IE00BFTCPJ56.SGD","LU0124676726.USD","LU0265550359.USD","LU1291159041.SGD","MRNX","LU1023059063.AUD","LU1941712264.USD","SG9999014559.SGD","LU1032466523.USD","LU1989771016.USD","LU2361044949.HKD","LU0965509283.SGD","LU2361045086.USD","LU2361044865.SGD","LU0689626769.HKD","LU1983299246.USD","LU0203347892.USD","LU0868494708.USD","BK4551","LU0211331839.USD","IYH","LU0122379950.USD","LU2324357040.USD","LU1116320737.USD","LU1066051811.HKD","LU0234572021.USD","IE00BJT1NW94.SGD","SGXZ57979304.SGD","LU0203345920.USD","LU1066053197.SGD","LU1162221912.USD","LU1061106388.HKD","BK4588","SG9999015358.SGD","SG9999001440.SGD","LU0823416689.USD","TRUH","LU2360032135.SGD","LU0432979614.USD","LU2456880835.USD","SG9999014575.USD","LU0208291251.USD","LU0265550946.USD","LU1571399168.USD","BK4585","WDNA","JDOC","SG9999014567.USD","BK4534","LU1989772923.USD","LU1941712348.USD","FTXH","VHT","IE00B1BXHZ80.USD","LU0477156953.USD","BK4548","LU1989772840.SGD","LU2125909247.SGD","LU2461242641.AUD","LU0006306889.USD","LU0130102774.USD","IE0002141913.USD","LU2236285917.USD","LU0320765489.SGD","LU0868494617.USD","LU0472753341.HKD","IE00B2B36J28.USD","LU1861559042.SGD","LU1093756325.SGD","LU1037948541.HKD","LU0511384066.AUD","LU2089984988.USD","TEMC","IE00BSNM7G36.USD","LU2491050071.SGD","PAWZ","LU2491049909.HKD","LU2417539215.USD","LU0072461881.USD","BK4516","LU2491050154.USD","LU0965508806.USD","LU2023250843.SGD","LU1066051225.USD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673011453","title":"Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011453","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011453?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:15","pubTimestamp":1791389721,"startTime":"0","endTime":"0","summary":"• Amgen rose due to positive analyst commentary and strong third-quarter financial forecasts.\n• Robust commercial execution and advancing clinical pipeline drove higher investor confidence.\n• Strong balance sheet and favorable technical indicators continue attracting institutional capital.","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262204356-market-movers-amgn-20261007","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","MHIP","XLV","IBBQ","IHE","IBB","ILDR","IDNA","LGHT","AGNG","BIB","PPH","FHLC","TRUH","GNOM","ELIL","MEDX","ELIS","LU1221951046.USD","BBH","MRNA","CURE","LLII","LLYX","IYH","HRTS","JDOC","LLYZ","MRNY","RXL","BMED","PJP","LLY","OZEM","TBXU","THNR","MRNX","CANC","LU1323610961.USD","TMED","MEDI","IXJ","JNJ","LU0708995401.HKD","FTXH","LU2242646821.SGD","PBE","AMGN","WDNA","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673526011","title":"S&P 500 Top and Bottom Performing Stocks at About 12:00 P.m. EDT","url":"https://stock-news.laohu8.com/highlight/detail?id=2673526011","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673526011?lang=en_us&edition=fundamental","pubTime":"2026-10-08 00:00","pubTimestamp":1791388809,"startTime":"0","endTime":"0","summary":"BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDTS&P 500.SPXTop PerformersPercent ChangeEli Lilly and CompanyLLY.N+3.9%ResMed Inc.RMD.N+3.6%Hewlett Packard Enterprise CompanyHPE.N+3.3%Rollins IncROL.N+3.2%Moderna, Inc.MRNA.OQ+3.2%Bottom PerformersPercent ChangeEMCOR Group, Inc.EME.N-6.3%Comfort Systems USA, Inc.FIX.N-6.3%Caterpillar IncCAT.N-5.9%Teradyne, Inc.TER.OQ-5.8%Allegion PLCALLE.N-5.7%As of 12:00 p.m., the S&P 500.SPXlost 27.60 points, or 0.35%, to 7,791.33 and had posted 8 new 52-week highs and 10 new lows.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL8N45T1JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0001KFT4U8.USD","LU0471298694.HKD","LU2023250330.USD","LU2471134523.USD","LU0109391861.USD","LU2552382215.SGD","TMED","LU1093756325.SGD","LU2023251221.USD","GPIX","LU1691799644.USD","LU2168563687.JPY","LU2552382058.USD","IJH","BK4139","IE00B775H168.HKD","LU1868836914.USD","LU2112291526.USD","BK4548","SPYH","FIX","ACWI","SG9999013999.USD","LU2896262040.SGD","EXI","LU2089283258.USD","BK4581","SG9999018865.SGD","LU0345770993.USD","SDS","LU2756315318.SGD","IE00BJJMRZ35.SGD","LU2168564149.EUR","RSPU","SG9999018857.SGD","VEU","IE00BSNM7G36.USD","LLYX","LU0054578231.USD","SPHQ","TRUH","UPRO","MRNX","LU1035775433.USD","LU2491049909.HKD","LU2213496289.HKD","LU1804176565.USD","LU1815336760.USD","IE00BN29S564.USD","SGXZ51526630.SGD","LU0256863902.USD","LU0320765059.SGD","VOOG","IE00BKPKM429.USD","EPAI","IE00B1XK9C88.USD","IE00B2B36J28.USD","AGNG","TERC","GDOC","LU1814569148.SGD","BK4568","LU0444971666.USD","LU1712237335.SGD","LU2746668974.SGD","LU0786609619.USD","BK4588","LU2125909916.SGD","BK4170","LU1642822529.SGD","LU2471134796.USD","SPLV","LU0048573561.USD","LU0109394709.USD","SG9999014914.USD","GSLC","LU2008162690.USD","PJP","BMAY","BK4516","LU0306807586.USD","LU0225283273.USD","LU0323591593.USD","LU0683600562.USD","IDNA","CATG","TRUI","XYLD","BK4007","LU1720051017.SGD","LU2750360997.AUD","LU1323610961.USD","LU2168564065.EUR","LU2265009873.SGD","IE00BN0W2W23.USD","LU0882574055.USD","LU0266013472.USD","LU2089984988.USD","LU2089284900.SGD","SG9999014906.USD","SPUU","MEDX","LU2168564222.USD","SMAX","LU1988902786.USD","LU2462157665.USD","LU0133085943.USD","HIBS","IYH","LU1868837136.USD","PPH","EME","HVAC","LU0963586101.USD","IE00B5TLWC47.USD","LU0114720955.EUR","IE00BFSS8Q28.SGD","LU0096364046.USD","LU0251142724.SGD","IE00B1BXHZ80.USD","OZEM","IVV","LU0345770308.USD","SPYG","BK4515","BK4585","BK4147","BK4597","LU0820561909.HKD","LU0354030511.USD","RMD","LU1267930730.SGD","LU0889565916.HKD","BK4082","IVW","LU0640476718.USD","LU0353189763.USD","LU1064131342.USD","IE00B7KXQ091.USD","LU0672654240.SGD","IJR","BK4120","JEPI","LU2264538146.SGD","IE00B4JS1V06.HKD","LU2237443549.SGD","LU2471134879.HKD","LU1232071149.USD","ETFT","LU0942090050.USD","LU2491050154.USD","IE0005OL40V9.USD","LU2552382132.HKD","GB00BDT5M118.USD","LU1551013342.USD","LU0203347892.USD","LU0061475181.USD","LU1861558580.USD","BK4520","SPXU","LU2236285917.USD","LU1093756168.USD","LU0964807845.USD","IE0004445015.USD","IE00BN0W2V16.EUR","LU2237443465.HKD","LU0094547139.USD","SPHD","SPMO","SPDN","ALLE","LU0225771236.USD","LU0820561818.USD","LU0417517546.SGD","LU0203345920.USD","SG9999015978.USD","LU2028103732.USD","LLYZ","ITOT","LU0353189680.USD","IE00BJLML261.HKD","LU2111349929.HKD","LU0708995401.HKD","IE0004445239.USD","LLY","LU0006061336.USD","MRNY","BK4504","BK4149","LU0234572021.USD","THNR","BK4551","IE00B4R5TH58.HKD","SPYQ","LU0943347566.SGD","LU2177674079.SGD","IE00BK4W5L77.USD","ELIL","LU0742534661.SGD","LU2271345857.HKD","BK4567","RSP","LU0238689110.USD","LU0456855351.SGD","LU1868836757.USD","IE00BK4W5M84.HKD","SG9999015945.SGD","SG9999015986.USD","SPYU","LU0006306889.USD","CURE","BK4599","TER","LU2237443978.SGD","LU0348723411.USD","LU1623119135.USD","SGXZ57979304.SGD","LU2462591350.SGD","DMAX","RXL","LU2543165471.USD","IE0034235188.USD","LU0823434583.USD","LU0320765992.SGD","LU2361044949.HKD","MMAX","HPE","LU2106854487.HKD","LU0689472784.USD","ILDR","LU0823416689.USD","SG9999017495.SGD","SGXZ31699556.SGD","HIBL","BK4501","IVE","LU2168564495.EUR","HPEL","LU2360106947.USD","LU0122379950.USD","LU2746668461.USD","LU2361045086.USD","BK4129","LU0203202063.USD","LU0321505439.SGD","SG9999015952.SGD","LU2750360641.GBP","VOO","LU2125909759.SGD","GNOM","LU0316494557.USD","WDNA","IE00BN0W2T93.GBP","SPYV","CANC","IE00BFTCPJ56.SGD","SG9999001176.SGD","LU1061106388.HKD","LU0256863811.USD","VBK","SPXL","IE00BKDWB100.SGD","LU0079474960.USD","ALLW","LU0158827781.USD","LU2756315664.SGD","IE00BMPRXQ63.HKD","LU0225284248.USD","MADE","LU0823434740.USD","IE00BWXC8680.SGD","IE00BFSS7M15.SGD","IE00BMPRXN33.USD","LU1057294990.SGD","LU1127390331.HKD","LU2361044865.SGD","RSPN","LU2023250504.SGD","SG9999014880.SGD","BK4086","LU0354030438.USD","BK4532","TSPY","CAT","BK4543","LU2357305700.SGD","LU2417539215.USD","VTV","SGXZ99366536.SGD","BK4533","SCHB","FTXH","LU0321505868.SGD","LU2456880835.USD","SGXZ81514606.USD","IXJ","LU2471134952.CNY","HRTS","LU1023059063.AUD","LU2468319806.SGD","BK4534","FHLC","LU1280957306.USD","ROL","RSHO","LU0466842654.USD","LU2491050071.SGD","LU1979441026.SGD","LLII","LU1861559042.SGD","SFY","LU0787776722.HKD","LU2461242641.AUD","LU2108987350.USD","VHT","SPGP","LU1720051108.HKD","SPXS","IE00BJJMRX11.SGD","LU0174119429.USD","LU1923622291.USD","MOAT","LU0106261372.USD","LU0210536198.USD","LU0053671581.USD","LU0251131958.USD","UXI","LU1868836591.USD","LU0170899867.USD","LU1983299246.USD","LU1629891620.HKD","LU0158827948.USD","LU1974910355.USD","LU1145028129.USD","LU0868494617.USD","NOBL","LU2063271972.USD","LGHT","LU1551013425.SGD","SPYM","LU1291159041.SGD","LU2602419157.SGD","JDOC","SG9999001176.USD","SSO","GASZ","IE0002141913.USD","DBSC","TERG","IE00BJJMRY28.SGD","LU0820562030.AUD","SH",".SPX","IHE","SPUS","YSPY","IE00BJT1NW94.SGD","LU0432979614.USD","LU0868494708.USD","LU2211815571.USD","XLG","SG9999014898.SGD","MHIP","LU1366192091.USD","LU0882574139.USD","LU2087625088.SGD","LU2237438978.USD","LU0203201768.USD","SCHX","HWAY","LU0385154629.USD","LU2237443622.USD","LU1548497426.USD","RSPA","LU0274383776.USD","MRNA","LU1069344957.HKD","LU1868837300.USD","LU2324357040.USD","IE00BMPRXR70.SGD","IE0009355771.USD","ELIS","MEDI","SPY","LU1917777945.USD","LU0058720904.USD","LU0289739699.SGD","XLV","XDTE","LU0198837287.USD","LU2237443895.HKD","LU2237443382.USD","LU0985481810.HKD","LU0097036916.USD","LU0957808578.USD","VTI","LU1989771016.USD","LU0471298777.SGD","IE00BD6J9T35.USD","SPYD","AIRR","VV","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2673011517","title":"Novartis announces FDA approval of Rhapsido for symptomatic dermographism","url":"https://stock-news.laohu8.com/highlight/detail?id=2673011517","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673011517?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:50","pubTimestamp":1791388212,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Food and Drug Administration approved Rhapsido as the first treatment for adults with symptomatic dermographism i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-symptomatic-dermographism-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IEIH","LU0320765489.SGD","LFSC","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BBP","BK4578","SYNB","TECB","IE00BFTCPJ56.SGD","PINK","BMED","IBB","BK4585","XLVX","MEDX","PSCH","IE0002141913.USD","LU0070302665.USD","BK4588","IE00B4R5TH58.HKD","IDNA","IE0009355771.USD","NVS","MEDI","GDOC","BK4007","IYH","NVIB","LU0211331839.USD","GNMX","FRTY","MRNX","LABU","TBXU","IE00BJT1NW94.SGD","MRNY","BK4532","RSPH","PPH","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673118620","title":"Novartis Rhapsido® (remibrutinib) receives FDA approval as first treatment for symptomatic dermographism (SD), expanding its use beyond chronic spontaneous urticaria (CSU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673118620","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673118620?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:45","pubTimestamp":1791387900,"startTime":"0","endTime":"0","summary":"In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with responses seen by Week 21SD is most prevalent type of chronic inducible ur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376686/0/en/novartis-rhapsido-remibrutinib-receives-fda-approval-as-first-treatment-for-symptomatic-dermographism-sd-expanding-its-use-beyond-chronic-spontaneous-urticaria-csu.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","RSPH","LU1244550221.USD","MEDI","BBP","BK4581","IE00B3S45H60.SGD","IAI","LU0267386448.USD","LU0795875169.SGD","SYNB","TBXU","LU1064131342.USD","IYH","LU0390134368.USD","BMED","IE00BZ1G4Q59.USD","KBWB","LU2023251221.USD","IDNA","GNMX","GDOC","LU2264538146.SGD","FRTY","LU2487616109.SGD","MRNY","PSCH","LABU","BK4504","LU0210528500.USD","LU1720051017.SGD","TECB","XLVX","LU0528227936.USD","BK4585","NVIB","LU0912757837.SGD","LU1720051108.HKD","MRNX","IBB","LU1668664300.SGD","LU2357305700.SGD","SD","LFSC","LU2028103732.USD","LU1791710582.SGD","LU1989772840.SGD","LU2089284900.SGD","PINK","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673019052","title":"Twist Bioscience Price Target Raised to $215.00/Share from $112.00 by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673019052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673019052?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:42","pubTimestamp":1791387720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TWST/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IDNA","ARKG","WDNA","BK4139","TWST","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673312019","title":"Moderna Price Target Raised to $95.00/Share from $89.00 by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2673312019","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673312019?lang=en_us&edition=fundamental","pubTime":"2026-10-07 23:02","pubTimestamp":1791385320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","WDNA","BK4532","BK4534","BK4568","BK4551","LGHT","BK4139","BK4548","IDNA","MRNX","BK4588","MRNA","BK4533","BK4585","BK4501","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673013770","title":"AIM ImmunoTech’s Strategy to Address Immune Resistance in Pancreatic Cancer Featured in BioTuesdays","url":"https://stock-news.laohu8.com/highlight/detail?id=2673013770","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673013770?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:14","pubTimestamp":1791378840,"startTime":"0","endTime":"0","summary":"CEO interview explores Ampligen’s potential to extend survival and improve quality of life as AIM advances toward pivotal development Access the article here OCALA, Fla., Oct.  07, 2026 (GLOBE NEWSWIR","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376540/29489/en/aim-immunotech-s-strategy-to-address-immune-resistance-in-pancreatic-cancer-featured-in-biotuesdays.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","MEDX","NVIB","HYLG","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673901317","title":"Morgan Stanley Adjusts Price Target on Moderna to $95 From $89","url":"https://stock-news.laohu8.com/highlight/detail?id=2673901317","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673901317?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:06","pubTimestamp":1791378407,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) has an average rating of hold and mean price target of $116.84, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4501","WDNA","BK4532","BK4533","BK4548","BK4585","MRNA","BK4588","MRNX","MRNY","BK4534","IDNA","LGHT","BK4568","BK4551","BK4139","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673772018","title":"Tempus AI announces multi-year collaboration with Moderna, Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2673772018","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673772018?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:35","pubTimestamp":1791376559,"startTime":"0","endTime":"0","summary":"Tempus (TEM) announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene, a novel, potential ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-multi-year-collaboration-with-moderna-merck-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-announces-multi-year-collaboration-with-moderna-merck-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0477156953.USD","BK4585","FTXH","LU0289739699.SGD","IE00BLSP4239.USD","IE0002141913.USD","BK4548","IE00B2B36J28.USD","SG9999015358.SGD","LU1201861249.SGD","LU0106261372.USD","LU1035773651.USD","BK4588","LU0124676726.USD","LU1989771016.USD","LU2491050154.USD","LU1699723380.USD","ARKG","LU0965508806.USD","LU2112291526.USD","LU2023250504.SGD","SG9999014567.USD","LU1929549753.HKD","LU1989772923.USD","LU1917777945.USD","BMED","SG9999014542.SGD","LU1057294990.SGD","BK4550","IE00B1BXHZ80.USD","LU2125909247.SGD","LU0289961442.SGD","GNOM","LU0648001328.SGD","LU0208291251.USD","LU1116320901.HKD","LU2357627491.SGD","LU0058720904.USD","LU0942090050.USD","LU1037948897.HKD","IYH","LU0234572021.USD","BK4568","LU1032466523.USD","LU0006306889.USD","LU1989772840.SGD","LU0965509101.SGD","LU0689626769.HKD","LU2089984988.USD","LU0980610538.SGD","LU1585245621.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU1069347547.HKD","LU2360032135.SGD","IHE","MRK","LU0130102774.USD","MRNX","LU0162691827.USD","LU0122379950.USD","LU1934455194.USD","LU0211331839.USD","LU0432979614.USD","LU0823416689.USD","LU1037948541.HKD","LU0072461881.USD","JDOC","LU2461242641.AUD","LU0265550946.USD","HEAL","LU0868494708.USD","LU1291159041.SGD","LU2491050071.SGD","TRUH","LU0861579265.USD","VHT","IE00BFTCPJ56.SGD","LU1066051498.USD","LU0472753341.HKD","LU0320765489.SGD","LU1093756325.SGD","LU2236285917.USD","LU2361044949.HKD","IE00BN8TJ469.HKD","SG9999015341.SGD","LU1023059063.AUD","LU2324357040.USD","LU0266013472.USD","LU1066051811.HKD","LU1861559042.SGD","LU0238689110.USD","LU0985320562.USD","LU1066051225.USD","LU0265550359.USD","IE00B4R5TH58.HKD","BK4611","IE00BJJMRZ35.SGD","SG9999001176.SGD","IE00BJT1NW94.SGD","LU1116320737.USD","LU1941712264.USD","LU2125154935.USD","LU2468319806.SGD","LU0965509010.AUD","LU2361045086.USD","HRTS","SGXZ57979304.SGD","LU0320765646.SGD","LU1934455863.HKD","LGHT","LU1941712348.USD","IE0009355771.USD","LU0289739343.SGD","SG9999002224.SGD","LU0098860793.USD","LU2417539215.USD","RXL","LU2106854487.HKD","MRNY","LU1934455277.USD","LU2023250843.SGD","SG9999001440.SGD","LU1066053197.SGD","LU1571399168.USD","LU1430594728.SGD","LU2125154778.USD","BK4551","TEMC","MRNA","BK4516","LU0069063385.USD","LU0965509283.SGD","WDNA","SG9999002232.USD","LU0130517989.USD","LU2433249047.HKD","SG9999014559.SGD","LU0070302665.USD","TEM","FHLC","BK4501","BK4534","IDNA","LU1983299246.USD","PAWZ","IE00BSNM7G36.USD","IE00BBT3K403.USD","LU1061106388.HKD","BK4121","BK4532","BK4613","GDOC","LU1923622614.USD","TEMT","LU2125909593.SGD","LU0868494617.USD","LU1974910355.USD","LU2491049909.HKD","IXJ","BK4559","LU0511384066.AUD","LU0203345920.USD","LU1861558580.USD","SG9999001176.USD","LU2456880835.USD","BK4139","LU0203347892.USD","LU1093756168.USD","LU2361044865.SGD","IE000M9KFDE8.USD","BK4533","PPH","SG9999014575.USD","XLV","LU0859254822.USD","LU0057025933.USD","LU1162221912.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018110","title":"Tempus Expands Multi-Year Collaboration with Moderna, Merck on V940 Melanoma Vaccine Commercialization Support","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018110","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018110?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376255,"startTime":"0","endTime":"0","summary":"Tempus expands multi-year collaboration with Moderna, Merck on V940 melanoma vaccine commercialization supportTempus expanded a multi-year collaboration with Moderna, Merck to support potential commer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDL3fGKs4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2433249047.HKD","SG9999001176.USD","LU0130517989.USD","LU1989772840.SGD","LU2106854487.HKD","LU2361045086.USD","LU2461242641.AUD","IE0002141913.USD","LU0098860793.USD","PAWZ","RXL","LU0477156953.USD","LU0648001328.SGD","LU2324357040.USD","LU0289739699.SGD","SG9999015341.SGD","GDOC","LU0868494708.USD","LU0289739343.SGD","LU1974910355.USD","TEMT","LU0006306889.USD","WDNA","LU0203345920.USD","MRK","IE00BN8TJ469.HKD","GNOM","LU1699723380.USD","SG9999015358.SGD","LU0211331839.USD","LU1037948541.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0511384066.AUD","BK4534","LU0238689110.USD","TEM","IE00BBT3K403.USD","LU1585245621.USD","LU1291159041.SGD","BK4548","IE00BLSP4452.SGD","BK4568","BMED","IE00BFTCPJ56.SGD","IXJ","LU1066051811.HKD","LU1989771016.USD","LU1861558580.USD","LU2360032135.SGD","IE00B1BXHZ80.USD","LU0057025933.USD","LU1983299246.USD","BK4611","LU0965509283.SGD","SG9999013999.USD","LU0124676726.USD","LU0234572021.USD","LU2125154778.USD","IE00BJT1NW94.SGD","LU2491049909.HKD","SG9999001176.SGD","BK4533","MRNA","LU0265550359.USD","LU1941712348.USD","LU0472753341.HKD","LU0985320562.USD","LU2468319806.SGD","LU0265550946.USD","LU0203347892.USD","LU1861559042.SGD","IE00BSNM7G36.USD","XLV","LGHT","LU0965509010.AUD","LU0072461881.USD","LU1037948897.HKD","LU1093756168.USD","BK4007","BK4139","LU0070302665.USD","LU1116320901.HKD","LU1066051225.USD","LU1934455277.USD","LU1917777945.USD","LU2417539215.USD","LU0861579265.USD","IE00B4R5TH58.HKD","LU1066053197.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","LU1923622614.USD","SG9999014542.SGD","BK4532","LU2357627491.SGD","LU0162691827.USD","LU0859254822.USD","FTXH","IDNA","LU0823416689.USD","LU1066051498.USD","LU1093756325.SGD","LU0965509101.SGD","IE00BLSP4239.USD","IYH","LU0689626769.HKD","LU2491050154.USD","MRNY","FHLC","PPH","LU2236285917.USD","BK4585","LU1941712264.USD","LU2112291526.USD","IE00B2B36J28.USD","LU0106261372.USD","LU0069063385.USD","LU0965508806.USD","BK4550","ARKG","LU2125154935.USD","BK4121","BK4551","LU1116320737.USD","LU1430594728.SGD","SG9999014575.USD","LU0266013472.USD","LU1069347547.HKD","LU2491050071.SGD","VHT","SG9999001440.SGD","LU1032466523.USD","SG9999002224.SGD","SG9999014559.SGD","LU2125909247.SGD","LU2361044949.HKD","LU0942090050.USD","BK4516","SG9999014567.USD","LU2125909593.SGD","JDOC","BK4559","TRUH","LU0058720904.USD","BK4613","LU1934455194.USD","IHE","LU1989772923.USD","LU0289961442.SGD","LU1162221912.USD","SG9999002232.USD","BK4588","LU0320765646.SGD","LU2023250843.SGD","LU2456880835.USD","IE0009355771.USD","SGXZ57979304.SGD","MRNX","LU1023059063.AUD","LU2089984988.USD","LU1201861249.SGD","TEMC","BK4501","LU1035773651.USD","LU0432979614.USD","HEAL","LU0122379950.USD","LU0980610538.SGD","LU1571399168.USD","LU0320765489.SGD","LU2361044865.SGD","LU1929549753.HKD","LU1934455863.HKD","LU2023250504.SGD","LU0208291251.USD","HRTS","LU0130102774.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673018165","title":"Tempus Announces Multi-Year Collaboration with Moderna and Merck","url":"https://stock-news.laohu8.com/highlight/detail?id=2673018165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673018165?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUA6NYCFM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765489.SGD","LU2361044865.SGD","BK4611","LU0472753341.HKD","IXJ","BK4501","MRK","LU1066053197.SGD","LU1162221912.USD","LU1035773651.USD","LU1037948897.HKD","LU2023250504.SGD","TEMC","IE00BLSP4452.SGD","VHT","LU1983299246.USD","LU1861558580.USD","LU1974910355.USD","LU0130102774.USD","LU0868494708.USD","LU0238689110.USD","LU0070302665.USD","LU1917777945.USD","LU1032466523.USD","IE00BLSP4239.USD","IE0009355771.USD","LU1923622614.USD","LU2125909593.SGD","LU2125154935.USD","BK4139","BK4007","GDOC","IYH","LU2236285917.USD","MRNA","LU1934455277.USD","LU2491050071.SGD","MRNY","LU1069347547.HKD","TEM","SG9999001176.USD","IE00B1BXHZ80.USD","LU0289739343.SGD","LU0289961442.SGD","LU2324357040.USD","LU1929549753.HKD","LU1989772840.SGD","LU2361045086.USD","LU1066051498.USD","TRUH","LU0320765646.SGD","LU2357627491.SGD","SG9999014542.SGD","IE00BFTCPJ56.SGD","LU0859254822.USD","LU1093756325.SGD","BMED","XLV","LU0861579265.USD","LU1989771016.USD","LU2491049909.HKD","LU0058720904.USD","LU0823416689.USD","BK4588","BK4559","LU1061106388.HKD","LU0965508806.USD","LU0006306889.USD","IE00B4R5TH58.HKD","SGXZ57979304.SGD","LU0122379950.USD","BK4121","LU0211331839.USD","LU2125154778.USD","LU1989772923.USD","LU0511384066.AUD","LU0124676726.USD","IE00BJT1NW94.SGD","WDNA","LU0965509101.SGD","LU2461242641.AUD","LU0965509010.AUD","HEAL","SG9999014559.SGD","PPH","GNOM","JDOC","LU2360032135.SGD","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU1093756168.USD","LU1201861249.SGD","LU0868494617.USD","LU1116320901.HKD","LU1037948541.HKD","LU0432979614.USD","LU1861559042.SGD","BK4550","BK4551","LU0057025933.USD","BK4534","LU2112291526.USD","RXL","LU0162691827.USD","LU1585245621.USD","LU0289739699.SGD","SG9999002224.SGD","FHLC","SG9999014567.USD","LU2456880835.USD","LGHT","LU0069063385.USD","LU0203347892.USD","LU0689626769.HKD","LU0265550359.USD","LU1934455863.HKD","LU2468319806.SGD","LU1066051811.HKD","LU2433249047.HKD","MRNX","FTXH","LU0965509283.SGD","LU0130517989.USD","LU1116320737.USD","LU0203345920.USD","LU0477156953.USD","SG9999015358.SGD","BK4516","LU0106261372.USD","LU0985320562.USD","LU0648001328.SGD","LU0208291251.USD","SG9999001176.SGD","LU0980610538.SGD","LU2023250843.SGD","IE00BSNM7G36.USD","LU2491050154.USD","BK4613","SG9999015341.SGD","BK4568","LU0265550946.USD","LU2089984988.USD","LU1430594728.SGD","LU0942090050.USD","LU0266013472.USD","LU1571399168.USD","SG9999002232.USD","TEMT","PAWZ","BK4585","LU1941712264.USD","IE0002141913.USD","BK4533","HRTS","LU2361044949.HKD","IDNA","LU1066051225.USD","LU0072461881.USD","LU1057294990.SGD","IHE","LU2417539215.USD","LU1941712348.USD","LU1934455194.USD","LU2125909247.SGD","IE00BN8TJ469.HKD","LU1291159041.SGD","ARKG","BK4548","LU2106854487.HKD","SG9999013999.USD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0234572021.USD","LU0098860793.USD","BK4532","LU1699723380.USD","LU1023059063.AUD","SG9999014575.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673182850","title":"Propanc Biopharma Reports Data Showing 90% Tumor Growth Inhibition with PRP in Pancreatic Cancer Models, Contrasting Profile with Revolution Medicines’ Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2673182850","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673182850?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:30","pubTimestamp":1791376200,"startTime":"0","endTime":"0","summary":"Preclinical package also shows more than 2.5-fold survival extension in advanced PDAC models; Company contrasts a non-RAS, differentiation-based mechanism with the clinical benchmark set by RASONQUE (","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376463/0/en/propanc-biopharma-reports-data-showing-90-tumor-growth-inhibition-with-prp-in-pancreatic-cancer-models-contrasting-profile-with-revolution-medicines-daraxonrasib.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","LU2298322129.HKD","BBH","BK4605","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU2357305700.SGD","ON","LU1978683503.SGD","BK4141","LU1983260115.SGD","LU1548497426.USD","BK4585","LU1854103824.USD","IE00BFMHRM44.USD","IE00BD6J9T35.USD","ONG","IE00BJJMRZ35.SGD","IE0002141913.USD","LU0724618433.USD","LU1861219969.SGD","LU1861220033.SGD","LU1720051108.HKD","LU2360107325.USD","BK4512","LU0109394709.USD","LU1861215975.USD","LU1720051017.SGD","IE00BJT1NW94.SGD","LU0348723411.USD","RVMD","IDNA","LU0124384867.USD","IE0009354923.USD","IE00BZ199S13.USD","BK4588","PTH","LU1854104046.USD","BK4139","ONX","LU1861214812.USD","IE0009355771.USD","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673975950","title":"Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2673975950","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673975950?lang=en_us&edition=fundamental","pubTime":"2026-10-07 19:00","pubTimestamp":1791370800,"startTime":"0","endTime":"0","summary":"– Data showed improvements in an objective measure of impaired eye movement associated with Parkinson’s disease, with a correlation between reductions in LRRK2 cerebrospinal fluid (CSF) biomarkers to ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376329/0/en/arvinas-shares-novel-oculomotor-and-biomarker-data-from-phase-1-clinical-trial-of-arv-102-in-patients-with-parkinson-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4109","LU2463526074.USD","CSF","HYLG","PSP","ASH","GDOC","NVIB","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065237","title":"Pandemic Panic Is Back on Wall Street. What to Know About the Russian Plague Scare","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065237?lang=en_us&edition=fundamental","pubTime":"2026-10-07 16:30","pubTimestamp":1791361800,"startTime":"0","endTime":"0","summary":"A mysterious death at a Russian research lab has sent health authorities scrambling and Wall Street into a familiar, headline-driven tailspin.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4501","BK4548","BK4534","BK4588","MRNA","BK4139","WDNA","LGHT","BK4533","BK4585","MRNX","GNOM","BK4568","NVAX","IDNA","MRNY","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673109650","title":"Barclays Remains a Buy on Twist Bioscience (TWST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673109650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673109650?lang=en_us&edition=fundamental","pubTime":"2026-10-07 15:57","pubTimestamp":1791359848,"startTime":"0","endTime":"0","summary":"Barclays analyst Luke Sergott maintained a Buy rating on Twist Bioscience today and set a price target of $215.00. According to TipRanks, Sergott i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-twist-bioscience-twst-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-remains-a-buy-on-twist-bioscience-twst-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","WDNA","BK4588","BK4139","GNOM","BK4585","TWST","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673098410","title":"Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673098410","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673098410?lang=en_us&edition=fundamental","pubTime":"2026-10-07 14:00","pubTimestamp":1791352800,"startTime":"0","endTime":"0","summary":"Licaminlimab genotype-based precision medicine approach for TNFR1-mediated dry eye disease in PREDICT-1 registrational symptoms trial on track for topline readout around year-end ZUG, Switzerland, Oct","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/07/3376181/0/en/oculis-to-highlight-licaminlimab-at-eyecelerator-aao-2026-and-partner-with-neuro-ophthalmology-subspecialty-day.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4141","IE00BFMHRM44.USD","ONX","LU1983260115.SGD","ON","LU0348723411.USD","BK4007","LU1861219969.SGD","LU1720051017.SGD","GDOC","BK4605","LU0124384867.USD","LU1861214812.USD","LU1978683503.SGD","BK4585","BMED","LU1548497426.USD","MEDX","ONG","LU1861220033.SGD","BK4512","IE00BD6J9T35.USD","LU1854103824.USD","LU1861215975.USD","LU2360107325.USD","OCS","LU2357305700.SGD","LU0724618433.USD","LU1720051108.HKD","LU1854104046.USD","IE00BZ199S13.USD","LU2298322129.HKD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}